Dietrich Stephan

Quick Facts

Full Name	Dietrich Stephan
Occupation	Geneticist
Date Of Birth	Aug 25, 1969(1969-08-25)
Age	55
Birthplace	Pittsburgh
Country	United States
Birth City	Pennsylvania
Horoscope	Virgo

Dietrich Stephan Biography

Dietrich Stephan is one of the most popular and richest Geneticist who was born on August 25, 1969 in Pittsburgh, Pennsylvania, United States.

In 2003, Stephan worked at Translational Genomics Research Institute (TGen) as a Senior Investigator and founding Chairman of the Department of Neurogenomics. He later served as the Deputy Director of Discovery Research at TGen. His laboratory has identified the genetic basis of 20 single gene disorders, and several dozen complex genetic disorders using high-throughput technologies and strategies, many if which were developed by his team

Stephan co-founded Navigenics, a personal genetics testing company, with oncologist David Agus, which was among the first direct-to-consumer genomics company (acquired by Life Technologies). In January 2007, bases on a publication from his group in Science, he co-founded Amnestix, a pharmaceutical company that focuses on the treatment of learning and memory impairment, acquired by Sygnis AG. In 2009, together with Vern Norviel, he co- founded Aueon, Inc., a biotechnology company that invented and patented tumor sequencing and targeted therapeutic selection for cancer patients which is now emerging as the standard of care in oncology. In 2011, he founded a next- generation genome sequencing and interpretation company, Lifecode (acquired by MedGenome). In 2014 he helped found Pendulum therapeutics and served at its Chairman of the Board until 2018. Stephan has served at Chairman of the Board of Peptilogics, a rational peptide therapeutics development company since

2015. In 2019, he founded NeuBase Therapeutics, a biotechnology company focused on developing antisense therapy.

Dietrich Stephan Net Worth

Dietrich Stephan is one of the richest Geneticist from United States. According to our analysis, Wikipedia, Forbes & Business Insider, Dietrich Stephan 's net worth $5 Million. (Last Update: December 11, 2023)

Dr. Dietrich A. Stephan, Ph.D. (born August 25, 1969) is an American human geneticist and entrepreneur who works in personalized medicine. Stephan is currently CEO of NeuBase Therapeutics and a General Partner in Cyto Ventures. Before NeuBase, Stephan was CEO of LifeX and Chairman and Professor of Human Genetics at the University of Pittsburgh. Prior, he was founding Chairman of the Neurogenomics Division at the Translational Genomics Research Institute. Stephan has founded or co-founded 14 biotechnology companies and advised many others. Stephan was co-founder of Navigenics, a personal genetics company.

Height, Weight & Body Measurements

Dietrich Stephan height Not available right now. Russell weight Not Known & body measurements will update soon.

Who is Dietrich Stephan Dating?

According to our records, Dietrich Stephan is possibily single & has not been previously engaged. As of December 1, 2023, Dietrich Stephan’s is not dating anyone.

Relationships Record : We have no records of past relationships for Dietrich Stephan. You may help us to build the dating records for Dietrich Stephan!

Facts & Trivia

Russell Ranked on the list of most popular Geneticist. Also ranked in the elit list of famous people born in United States. Dietrich Stephan celebrates birthday on August 25 of every year.